Furthermore, knockout of MUC1 in tumor cells resulted in higher sensitivity to EGFR inhibitors, and activated EGFR stimulated MUC1 expression in human uterine and pancreatic cancer cell lines (55). Here, MUC1 is linked to pancreatic neoplasm.